HETSOLID

This brand name is authorized in Nigeria.

Active ingredients

The drug HETSOLID contains one active pharmaceutical ingredient (API):

1
UNII 2E18WX195X - DABIGATRAN ETEXILATE
 

Dabigatran etexilate is a small molecule prodrug which does not exhibit any pharmacological activity. After oral administration, dabigatran etexilate is rapidly absorbed and converted to dabigatran by esterase-catalysed hydrolysis in plasma and in the liver. Dabigatran is a potent, competitive, reversible direct thrombin inhibitor and is the main active principle in plasma.

 
Read more about Dabigatran

Packages

This drug has been approved in Nigeria as follows:

Identifier Form Presentation Description Approval
A4-101274 Capsule Hetsolid 75 mg Capsules CAP 75 mg 10 x 10's (in blisters) Capsule Cream opaque cap/cream opaque body size '2' HMPC capsules imprinted with 'H' on cap and 'D10' on body with black ink, filled with mixture of off white to yellowish white pellets 30/04/2025
A4-101278 Capsule Hetsolid 110 mg Capsules CAP 110 mg 10 x 10's (in blisters) Capsule Cream opaque cap/cream opaque body size 'I' HMPC capsules imprinted with 'H' on cap and 'D16' on body with black ink, filled with mixture of off white to yellowish white pellets 30/04/2025
A4-101279 Capsule Hetsolid 150 mg Capsules CAP 150 mg 10 x 10's (in blisters) Capsule Light blue opaque cap/cream opaque body size '0' HMPC capsules imprinted with 'H' on cap and 'D11' on body with black ink, filled with mixture of off white to yellowish white pellets 30/04/2025

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group Classification
B01AE07 Dabigatran etexilate B Blood and blood forming organs → B01 Antithrombotic agents → B01A Antithrombotic agents → B01AE Direct thrombin inhibitors
Discover more medicines within B01AE07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country Identification scheme Identifier(s)
NG Registered Drug Product Database A4-101274, A4-101278, A4-101279

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.